← Leaderboards
Shawn Kucera
Cassava Sciences, Inc
$1,114,493
Attributed
$2,228,986
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2017–19$2M$1.5M$1M$500K$0
'17
'18
'19
Funding mix
By agency
NIH$2,228,986 · 1
By mechanism
R44$2,228,986 · 1
Top collaborators
- Michael S Zamloot2 shared
Most similar at Cassava Sciences, Inc
Same institution · by research overlap
- Lindsay H Burns$16,572,741
- Michael S Zamloot$1,214,493
Others in their field
Other Emerging Leaders on “Evaluation”
- Valerie Koch · University Corporation For Atmospheric Res$265,601,376
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,645,551
- Beth Baseler · Leidos Biomedical Research, Inc.$208,220,586
- John E West · University Of Texas At Austin$131,399,667
- Kimberly Smith · Ppd Development Lp$115,671,664
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,805,377
Research focus
EvaluationAddictionAbsorptionAdhesivesAnalytical MethodArtificial MembranesBaseAdhesionsChildClinical LotClinical TrialsConformerCrystallinityCrystallizationDangerousnessDeglutitionDermalDesignDissociationDoseDrug KineticsEnhancersEnsureExcipients